Second only to THC, Cannabidiol (CBD) is one of the main non-psychoactive cannabinoids. With such strong anti-psychotic properties, it’s no wonder why CBD is extremely useful to individuals that suffer from mental illnesses involving psychoses. It also possesses more powerful anti- inflammatory properties than THC or Ibuprofen, and has been shown to manage pain and tumors as well as THC, if not better. In fact, CBD is therapeutic in a great many cases and appears to alter how the body is affected by THC, which causes its effects to be therapeutic rather than psychoactive. It has a vast array of uses spanning from mental illness relief – from anxiety, for example – to physical pain relief, and has been recommended for use in children and the elderly due to its mild side effects.
Boasting many potentially beneficial properties, CBD has many therapeutic uses. These range from simple pain relief to relieving the effects of depression, and can also be used to aid in decreasing inflammation. The cannabinoid even has the potential to aid in the fight against cancer while also helping to make the side-effects of chemotherapy more bearable through its ability to serve as a sleep aid, reduce nausea, vomiting, and anxiety.
Research into CBD is ongoing, most notably in a California medical center, and a report published in 2007 discusses the effect of the cannabinoid on a gene that causes the development of cancer cells: Id-1. It has been shown that CBD effectively inhibits this gene and stops the progress of cancer cells and, while more research needs to be conducted to further investigate this claim, potentially has the ability to stop or reverse tumor growth.
Two clinical trials conducted by British pharmaceutical company GW Pharmaceuticals, approved by the Food and Drug Administration (FDA) in October 2013, are set to explore the potential benefits and therapeutic value of using CBD to treat epilepsy in children. Intractable epilepsy in children, in the form of a relatively unknown epilepsy-related illness known as Dravet Syndrome, causes seizures – the first usually occurring before the child’s first birthday – that have been known to last for longer than 24 hours.
CBD possesses antidepressant properties similar to those of tricyclic antidepressant Imipramine, and provides relief from depression and anxiety through the stimulation of a specific cerebral receptor known as 5-HT1a – the part of the brain involved in processing serotonin.
With its antipsychotic properties, CBD seems like a good choice for the treatment of individuals with psychotic tendencies or related disorders. Research is currently being conducted to assess CBD and its chemical profile, which seems to be similar to that of various atypical antipsychotic drugs.
Research into a new class of IBD treatment drugs is currently considering the use of CBD and evaluating its potential to control the discomfort and inflammatory responses that are the result of Crohn’s disease and IBD.
With strong neuroprotective and antioxidative properties, research is ongoing to explore CBD’s potential to counteract the effects that age has on the human brain – for example, Alzheimer’s, dementia, and memory loss.